Plain-English translation of NCT06691425 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether combining with stereotactic body radiation therapy (SBRT)—a type of focused, high-dose radiation delivered in just a few sessions—works better than alone for people with pancreatic cancer that cannot be surgically removed. Participants will first receive 12 weeks of standard , then be randomly assigned to either continue with alone or add SBRT to their treatment plan.
Pancreatic cancer is difficult to treat, especially when surgery is not an option. While is the standard approach, researchers want to see if adding this newer radiation technique might improve survival and give more patients a chance at surgery later.
You likely qualify if…
You likely don't qualify if…
You will begin with 12 weeks of standard as an outpatient. After that, you'll have scans to check how well the worked. If you qualify, you'll be randomly assigned to one of two groups: one group continues with more alone, while the other group receives additional plus 5 sessions of focused radiation therapy over about 2 weeks. Throughout your participation, you'll have regular clinic visits, blood tests, and imaging scans to monitor your progress and check whether surgery becomes possible. The entire study includes a screening phase, treatment phase, and follow-up visits.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
Belgium